Skip to main content
. 2024 Jan 11;16(2):324. doi: 10.3390/cancers16020324

Table 3.

Comparison of biomarkers of metabolic and cardiovascular risk between cases and controls.

Variables Cases
[Mean (SD)]
Controls
[Mean (SD)]
p Value
Glucose (mg/dL) 83.36 (5.80) 75.21 (14.06) 0.056
Total cholesterol (mg/dL) 166.01 (55.78) 158.57 (29.44) 0.191
Triglycerides (mg/dL) 92.64 (50.19) 85.21 (37.90) 0.662
HDL (mg/dL) 49.21 (20.09) 48.57 (8.30) 0.913
LDL (mg/dL) 105.50 (28.05) 93.00 (25.61) 0.229
Lp(a) (mg/dL) 58.52 (71.46) 35.47 (53.10) 0.342
Apo B (mg/dL) 19.98 (8.18) 20.91 (9.13) 0.769
Leptin (ng/mL) 6.22 (4.79) 4.26 (4.84) 0.290
TNFα (pg/mL) 3.13 (1.01) 3.30 (0.84) 0.633
IL 1-β (pg/mL) 0.78 (0.46) 0.49 (0.29) 0.179
IL-10 (pg/mL) 0.36 (0.33) 0.48 (0.46) 0.568
IL-6 (pg/mL) 0.60 (0.64) 0.22 (0.33) 0.176
Endothelin-1 (pg/mL) 1.28 (0.41) 0.99 (0.17) 0.025 *
Adiponectin (μg/mL) 10.91 (3.57) 10.91 (3.47) 0.998

Student’s t test was used for the comparison of variables. * p value < 0.05. HDL: high-density lipoprotein; IL: interleukin; LDL: low-density lipoprotein; SD: standard deviation; TNF: tumor necrosis factor; Apo B: apolipoprotein B; Lp(a): lipoprotein (a).